Position in INSM
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$165,809,280
-$6,222,298 QoQ
Shares Held
1,014,000
+2.6% QoQ
Ownership
0.468%
of shares outstanding
% of Portfolio
7.85%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
7 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in INSM Over Time
Shares Held
Position Value (USD)
Derivatives in INSM
reported options exposure · as of Jun 30, 2025CallValue
$30,292,640
CallShares
301,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026NWI MANAGEMENT LP holds $197,826,216 across 4 Biotechnology names. INSM ranks #1 (83.8% of the industry book) .
All Filings in INSM
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $165,809,280 | 1,014,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $172,031,578 | 988,460 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $147,034,210 | 1,021,000 | Shares | Sole | 2025-12-05 | |
| 2025-06-30 | $30,292,640 | 301,000 | Call | Sole | 2025-12-05 | |
| 2025-06-30 | $72,460,800 | 720,000 | Shares | Sole | 2025-12-05 | |
| 2025-03-31 | $34,330,500 | 450,000 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $19,262,160 | 279,000 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $7,120,420 | 97,540 | Shares | Sole | 2024-11-13 | |
| No filing history on record for this holder in this stock. | ||||||